These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14667282)

  • 1. Breast enhanced scintigraphy testing distinguishes between normal, inflammatory breast changes, and breast cancer: a prospective analysis and comparison with mammography.
    Fleming RM; Dooley WC
    Integr Cancer Ther; 2002 Sep; 1(3):238-45. PubMed ID: 14667282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial uptake of sestamibi distinguishes between normal, inflammatory breast changes, pre-cancers, and infiltrating breast cancer.
    Fleming RM
    Integr Cancer Ther; 2002 Sep; 1(3):229-37. PubMed ID: 14667281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of breast tumors by scintigraphy versus mammography].
    García-Fernández R; Maravilla A; Pichardo-Romero P; Rubio V; Iwasaki-Otake L; Arévila-Ceballos N
    Rev Invest Clin; 1998; 50(1):53-6. PubMed ID: 9608791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
    Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
    Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there differences in breast tissue as a result of hormone replacement therapy? Can BEST imaging distinguish these differences?
    Fleming RM
    Integr Cancer Ther; 2003 Sep; 2(3):229-34. PubMed ID: 15035885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of MIBI scintigraphy in the early detection of breast cancer].
    Tanyi M; Fülöp B; Garami Z; Garai I; Tanyi J; Lukács G
    Magy Seb; 2001 Apr; 54(2):118-22. PubMed ID: 11339088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast lesions: imaging with contrast-enhanced subharmonic US--initial experience.
    Forsberg F; Piccoli CW; Merton DA; Palazzo JJ; Hall AL
    Radiology; 2007 Sep; 244(3):718-26. PubMed ID: 17690324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
    Brem RF; Fishman M; Rapelyea JA
    Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of breast-specific gamma imaging (BSGI) for breast cancer in Korea: a comparative study.
    Lee A; Chang J; Lim W; Kim BS; Lee JE; Cha ES; Moon BI
    Breast J; 2012 Sep; 18(5):453-8. PubMed ID: 22897514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mammography in the diagnosis and treatment of non-puerperal mastitis (author's transl)].
    Gregl A; Schaal HJ; Müller I; Peiper HJ
    Rofo; 1979 Mar; 130(3):342-7. PubMed ID: 155579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.
    Rhodes DJ; Hruska CB; Phillips SW; Whaley DH; O'Connor MK
    Radiology; 2011 Jan; 258(1):106-18. PubMed ID: 21045179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer.
    Lee VW; Sax EJ; McAneny DB; Pollack S; Blanchard RA; Beazley RM; Kavanah MT; Ward RJ
    J Nucl Med; 1993 Dec; 34(12):2095-100. PubMed ID: 8254394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
    Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
    Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
    Lam WW; Yang WT; Chan YL; Stewart IE; King W; Metreweli C
    Br J Radiol; 1996 Dec; 69(828):1152-8. PubMed ID: 9135472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative analysis of early diagnostic tools for breast cancer].
    Shen SJ; Sun Q; Xu YL; Zhou YD; Guan JH; Mao F; Lin Y; Wang XJ; Han SM
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):877-80. PubMed ID: 23291142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palpable breast thickening: role of mammography and US in cancer detection.
    Kaiser JS; Helvie MA; Blacklaw RL; Roubidoux MA
    Radiology; 2002 Jun; 223(3):839-44. PubMed ID: 12034957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer.
    Boné B; Wiberg MK; Szabó BK; Szakos A; Danielsson R
    Acta Radiol; 2003 Jan; 44(1):28-34. PubMed ID: 12630995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphy of the female breast with Tc-99m-DTPA: a prospective blind evaluation.
    Pauwels EK; Den Outer AJ; Hermans J; Obermann WR; Zwaveling A
    Am J Physiol Imaging; 1986; 1(2):91-5. PubMed ID: 3330444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis, incidence and course of nonpuerperal mastitis].
    Gölles M; Kopp W; Beaufort F
    Radiologe; 1985 Feb; 25(2):87-92. PubMed ID: 4039457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.